Announcements Trials
Browse Landscape Eligibility

Clinical Trials

10 trials
RecentStart dateEnrollment
Ice × Clear all

Phase

Phase 2 4Phase NA 2Phase 3 2Phase 4 1Phase 1/2 1

Status

Completed 4Unknown 3Terminated 2Recruiting 1

Sponsor Class

OTHER 6INDUSTRY 3OTHER_GOV 1

Study Type

Interventional 10

Sponsor

Cancer Type

Lymphoid 5Breast 2Genitourinary 1

Conditions

Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, T-Cell, Peripheral 2Lymphoma, Large B-Cell, Diffuse 2Breast Neoplasms 2Urologic Diseases 1Taste Disorders 1Renal Insufficiency 1Recurrence 1Malnutrition 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Kidney Neoplasms 1Kidney Diseases 1Intracranial Germ Cell Tumors 1Hypothermia 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 2848Cisplatin 2837Carboplatin 2635Radiotherapy 2522Paclitaxel 2424Gemcitabine 2263pembrolizumab 2099Docetaxel 1978Bevacizumab 1966Fluorouracil 1660Capecitabine 1640Oxaliplatin 1551Dexamethasone 1417Nivolumab 1394Doxorubicin 1349Rituximab 1338Magnetic Resonance Spectroscopy 1229Etoposide 1198Irinotecan 1122Leucovorin 1096Drug Therapy 1062Cytarabine 1010Pemetrexed 944fludarabine 933Specimen Handling 875Vincristine 857Prednisone 851Lenalidomide 838Trastuzumab 837Cetuximab 831

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT04425070 2026-01-05

TOUCH

Antengene Corporation

Phase 1/2 Terminated
56 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral, Lymphoma, Extranodal NK-T-Cell

NCT06520163 2025-12-04

Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma

The Affiliated People's Hospital of Ningbo University

Phase 3 Recruiting
99 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT06594354 2025-06-19

Oral Cryotherapy Applied to Patients Undergoing Chemotherapy

Karadeniz Technical University

Phase NA Completed
65 enrolled

Neoplasms, Taste Disorders, Malnutrition

NCT04822597 2023-08-03

Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer

University of Wisconsin, Madison

Phase 3 Completed
167 enrolled 21 charts
Breast

Breast Neoplasms

NCT01453205 2018-03-12

A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

MedImmune LLC

Phase 2 Completed
187 enrolled 21 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT01529658 2016-10-27

Renal Hypothermia During Partial Nephrectomy

Ottawa Hospital Research Institute

Phase NA Unknown
184 enrolled
Genitourinary

Carcinoma, Renal Cell, Hypothermia, Kidney Diseases, Kidney Neoplasms, Neoplasms, Urologic Diseases, Renal Insufficiency

NCT02856997 2016-08-05

Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Unknown
35 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT00020722 2016-02-17

Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer

Barbara Ann Karmanos Cancer Institute

Phase 2 Terminated
7 enrolled 3 charts
Breast

Breast Neoplasms

NCT01424839 2015-06-04

SIOPCNSGCTII

University Hospital Muenster

Phase 4 Unknown
400 enrolled

Intracranial Germ Cell Tumors

NCT00823719 2013-03-12

Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL)

GlaxoSmithKline

Phase 2 Completed
61 enrolled 25 charts
Lymphoid

Lymphoma, Non-Hodgkin, Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡